Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aquestive Therapeutics Inc.

2.51
+0.01000.40%
Post-market: 2.520.0108+0.43%19:25 EDT
Volume:1.11M
Turnover:2.78M
Market Cap:248.17M
PE:-4.93
High:2.58
Open:2.50
Low:2.47
Close:2.50
Loading ...

Aquestive Therapeutics, Inc. Q4 Adjusted Ebitda USD -11.029 Million

THOMSON REUTERS
·
06 Mar

Aquestive Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
04 Mar

Aquestive Therapeutics to Participate in Two Upcoming Conferences in March

GlobeNewswire
·
26 Feb

Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?

Zacks
·
13 Feb

Aquestive Therapeutics to present new findings at AAAAI meeting

TIPRANKS
·
12 Feb

Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting

GlobeNewswire
·
12 Feb

Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference

GlobeNewswire
·
04 Feb

Institutional investors own a significant stake of 49% in Aquestive Therapeutics, Inc. (NASDAQ:AQST)

Simply Wall St.
·
27 Jan

Lake Street Remains a Buy on Aquestive Therapeutics (AQST)

TIPRANKS
·
13 Jan

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

THOMSON REUTERS
·
13 Jan

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

GlobeNewswire
·
13 Jan

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires Live
·
20 Dec 2024

Aquestive Therapeutics Gains FDA Orphan Drug Exclusivity for Pediatric Seizure Treatment

GuruFocus.com
·
20 Dec 2024

Aquestive Therapeutics Says FDA Grants Orphan Drug Exclusivity for Libervant Buccal Film to Treat Seizure Clusters

MT Newswires Live
·
19 Dec 2024

Aquestive Therapeutics receives FDA ODE for Libervant Buccal Film

TIPRANKS
·
19 Dec 2024

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (Diazepam) Buccal Film in Pediatric Patients With Seizure Clusters Ages Two to Five

THOMSON REUTERS
·
19 Dec 2024

Aquestive Therapeutics Inc - Ode Granted to Libervant for Patients Aged 2-5 Extends to April 2031

THOMSON REUTERS
·
19 Dec 2024

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five

GlobeNewswire
·
19 Dec 2024

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

Benzinga
·
18 Dec 2024

Cantor Fitzgerald Initiates Aquestive Therapeutics at Overweight With $17 Price Target

MT Newswires Live
·
17 Dec 2024